Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study on Long-Term Safety of ZYN002 Gel for Children, Adolescents, and Young Adults with Fragile X Syndrome
IrelandStudy on the Effectiveness and Safety of Perampanel for Children with Epilepsy
BelgiumStudy on the Safety and Effects of PTC518 for Patients with Huntington's Disease
AustriaStudy on the Effectiveness and Safety of NT 201 for Treating Lower Limb Spasticity in Children and Adolescents with Cerebral Palsy
LatviaStudy on Dinutuximab Beta and Chemotherapy for Patients with Neuroblastoma Resistant to Standard Treatment or with Relapsed Disease
PolandStudy on Baclofen for Pulmonary and Sleep Disorders in Spinal Cord Injury Patients
The NetherlandsStudy on Ublituximab and Drug Combination for Patients with Myasthenia Gravis or Relapsing Multiple Sclerosis
PolandStudy on Cannabidiol as Add-on Therapy for Seizures in Patients Aged 1-65 with Tuberous Sclerosis Complex
PolandStudy on the Effects of Inebilizumab for Adults with Myasthenia Gravis
FranceStudy on Selumetinib for Children Aged 1 to 6 with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas
GermanyStudy on the Long-term Safety of Cenobamate for Patients with Primary Generalized Tonic-Clonic Seizures
GermanyStudy on the Effectiveness and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
CzechiaThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
